Article
Glucose-regulated protein 78 regulates multiple malignant phenotypes in head and neck cancer and may serve as a molecular target of therapeutic intervention.
Molecular cancer therapeutics - 1 Sept 2008
Chiu Ching-Chi, Lin Chien-Yu, Lee Li-Yu, Chen Yin-Ju, Kuo Ting-Fang, Chang Joseph Tung-Chieh, Liao Chun-Ta, Wang Hung-Ming, Yen Tzu-Chen, Shen Chia-Rui, Liao Shuen-Kuei, Cheng Ann-Joy
Abstract excerpt
Glucose-regulated protein 78 (Grp78) is an endoplasmic reticulum chaperone protein and is overexpressed in various cancers. However, it is unclear how significance of this molecule play an active role contributing to the oncogenic effect of head and neck cancer (HNC). To investigate the potential function of Grp78, six HNC cell lines were used. We found that Grp78 is highly expressed in all six cell lines and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
